Simvastatin

apolipoprotein A1 ; Homo sapiens







26 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29447225 Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy. 2018 1
2 26336957 Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk. 2015 Sep 4 1
3 24325778 Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes. 2014 1
4 23728830 Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial. 2013 Oct 1
5 23866306 Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects. 2013 Jul 16 1
6 21115572 Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes. 2011 Jan 1
7 19327776 Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL). 2009 Aug 1
8 19555253 Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients. 2009 Aug 2
9 18270459 HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in type 2 diabetic patients with hyperlipidemia. 2008 Feb 2
10 15585213 Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men. 2005 Jan 6
11 15474503 Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell. 2004 Nov 12 2
12 12637338 Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. 2003 May 1 1
13 14640465 Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups. 2003 Nov 4
14 12048122 Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes. 2002 Jul 4
15 12404199 Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial. 2002 Nov 1
16 10335764 Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. 1999 May 15 2
17 10563066 International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment of patients with primary hypercholesterolaemia. International Cerivastatin Study Group. 1999 Jun 1
18 9566646 Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. 1998 Feb 1
19 9809932 The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. 1998 Nov 1
20 8880287 The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride level. 1996 Sep 1
21 8122478 Efficacy and tolerability of simvastatin 20 mg vs pravastatin 20 mg in patients with primary hypercholesterolemia. European Study Group. 1993 2
22 8194433 [Clinical evaluation of simvastatin in the treatment of hyperlipidemia]. 1993 Aug 1
23 8399632 Dislipemia in patients undergoing continuous ambulatory peritoneal dialysis: pharmacological therapy (simvastatin) versus hemodialysis. 1993 2
24 2502417 Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia. 1989 1
25 2646895 Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II). 1989 Mar 15 1
26 2894548 Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. 1988 Mar 19 1